These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31689258)

  • 21. The Role of State Medicaid Expansions in Integrating Comprehensive Mental Health Services into Opioid Treatment Programs: Differences Across the Rural/Urban Continuum.
    Pro G; Giano Z; Camplain R; Haberstroh S; Camplain C; Wheeler D; Hubach RD; Baldwin JA
    Community Ment Health J; 2021 Aug; 57(6):1017-1022. PubMed ID: 33033972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial strategies for integrating buprenorphine into HIV care settings in the United States.
    Sullivan LE; Bruce RD; Haltiwanger D; Lucas GM; Eldred L; Finkelstein R; Fiellin DA
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S191-6. PubMed ID: 17109306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating reproductive health care into substance use disorder services.
    McQuade M; Reddy N; Barbour K; Owens L
    Int Rev Psychiatry; 2021 Sep; 33(6):572-578. PubMed ID: 33974476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
    Astone JM; Strauss SM; Hagan H; Des Jarlais DC
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Need, demand and missed opportunities for integrated reproductive health-HIV care in Kenya and Swaziland: evidence from household surveys.
    Mak J; Birdthistle I; Church K; Friend-Du Preez N; Kivunaga J; Kikuvi J; Masuku R; ; Mayhew SH
    AIDS; 2013 Oct; 27 Suppl 1():S55-63. PubMed ID: 24088685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strengthening integration of family planning with HIV/AIDS and other services: experience from three Kenyan cities.
    Mutisya R; Wambua J; Nyachae P; Kamau M; Karnad SR; Kabue M
    Reprod Health; 2019 May; 16(Suppl 1):62. PubMed ID: 31138271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Medication-Assisted Treatment for Opioid Addiction on Medicaid Expenditures and Health Services Utilization Rates in Vermont.
    Mohlman MK; Tanzman B; Finison K; Pinette M; Jones C
    J Subst Abuse Treat; 2016 Aug; 67():9-14. PubMed ID: 27296656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and people who use drugs; seizing opportunity in times of chaos.
    Wisse E; Burke-Shyne N; Chang J; Southwell M
    Int J Drug Policy; 2021 Apr; 90():103097. PubMed ID: 33485187
    [No Abstract]   [Full Text] [Related]  

  • 32. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?
    Friedmann PD; D'Aunno TA; Jin L; Alexander JA
    Health Serv Res; 2000 Jun; 35(2):443-65. PubMed ID: 10857471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating reproductive health services in a reforming health sector: the case of Tanzania.
    Oliff M; Mayaud P; Brugha R; Semakafu AM
    Reprod Health Matters; 2003 May; 11(21):37-48. PubMed ID: 12800702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Reproductive Healthcare for Women With Opioid Use Disorder.
    Smith C; Morse E; Busby S
    J Perinat Neonatal Nurs; 2019; 33(2):E3-E11. PubMed ID: 31021945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
    Yang JC; Roman-Urrestarazu A; Brayne C
    PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
    Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reproductive health and family planning needs among HIV-infected women in Sub-Saharan Africa.
    Sarnquist CC; Rahangdale L; Maldonado Y
    Curr HIV Res; 2013 Mar; 11(2):160-8. PubMed ID: 23432491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceptions and Experiences of Integrated Service Delivery Among Women Living with HIV Attending Reproductive Health Services in Kenya: A Mixed Methods Study.
    Colombini M; Mayhew SH; Mutemwa R; Kivunaga J; Ndwiga C;
    AIDS Behav; 2016 Sep; 20(9):2130-40. PubMed ID: 27071390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Nov; 61(RR-5):1-40. PubMed ID: 23135062
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.